Long-term safety and effectiveness of fampridine

9th March 2017

Researchers find fampridine safe and effective in the long term for improving walking speed

Lifestyle risk factors in the progression of multiple sclerosis

8th March 2017

Low vitamin D levels and smoking consistently associated with MS progression

Applications for MSIF fellowships and grants now open

1st March 2017

The deadline for applications for McDonald fellowships and Du Pré Grants is 30 June 2017

Cognitive impairment and sodium concentration in gray matter

12th February 2017

Advanced MRI shows sodium concentration in gray matter better explains cognition than atrophy in MS

Early treatment benefits individuals with a first attack resembling MS

11th February 2017

People diagnosed with CIS who received early treatment are less likely to convert to MS

A simple specialised eye examination can show the effect of MS drugs

10th February 2017

Optical coherence tomography may be used to test the effect of drugs in relapsing-remitting MS trials

Early evidence of multiple sclerosis in high risk family members

9th February 2017

Some family members of people with MS show possible early signs of the disease without symptoms

Biomarker for predicting MS risk after clinically isolated syndrome

8th February 2017

A biomarker in cerebrospinal fluid is associated with a higher risk of MS in people with CIS

7th Russian patients congress

27th January 2017

The 7th All-Russian Congress of patients was held in Moscow and attended by over 424 delegates

Portuguese Politicians experience MS symptoms

18th January 2017

National Multiple Sclerosis Day marked across Portugal

Neonatal vitamin D and the risk of MS

17th January 2017

Further evidence shows the role of vitamin D in MS risk, especially during pregnancy

Recruitment complete for new progressive MS drug trial

15th January 2017

250 people with progressive MS are taking part in the SPRINT-MS trial for ibudilast